Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · Real-Time Price · USD
1.750
-0.010 (-0.57%)
Dec 20, 2024, 4:00 PM EST - Market closed
Aileron Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$19.00
Upside
+985.71%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $9 → $19 | Strong Buy | Maintains | $9 → $19 | +985.71% | Apr 18, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Hold → Strong Buy Upgrades $9 | Hold → Strong Buy | Upgrades | $9 | +414.29% | Dec 1, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $20 | Strong Buy | Maintains | $40 → $20 | +1,042.86% | Jun 30, 2022 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 29, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $40 | Strong Buy | Maintains | $60 → $40 | +2,185.71% | Jun 5, 2020 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $120 → $60 | Strong Buy | Maintains | $120 → $60 | +3,328.57% | Mar 31, 2020 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $380 → $100 | Strong Buy | Maintains | $380 → $100 | +5,614.29% | Apr 9, 2019 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $140 | Strong Buy | Initiates | $140 | +7,900.00% | Mar 11, 2019 |
| Jefferies | Jefferies | Strong Buy Initiates $400 | Strong Buy | Initiates | $400 | +22,757.14% | Jul 24, 2017 |
| B of A Securities | B of A Securities | Strong Buy Initiates $380 | Strong Buy | Initiates | $380 | +21,614.29% | Jul 24, 2017 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $380 | Strong Buy | Initiates | $380 | +21,614.29% | Jul 24, 2017 |